Journals / Acıbadem Üniversitesi Sağlık Bilimleri Dergisi / 2019 / Cilt: 10 - Sayı: 4

INVESTIGATION OF ENDOTHELIAL DYSFUNCTION AND THE RISK OF ATHEROSCLEROSIS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME

Obstrüktif Uyku Apne Sendromu (OUAS) Saptanan Hastalarda Vasküler Fonksiyon Bozukluğu ve Ateroskleroz Riskinin Değerlendirilmesi

Pages
627–633
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our study, no differences were shown between the progression of the disease and endothelial dysfunction and pre-atherosclerosis markers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate endothelial dysfunction and pre-atherosclerosis in patients with Obstructive Sleep Apnea Syndrome (OSAS) by using several parameters including Brachial Artery Flow-Mediated Vasodilation (BAFMV), Carotid Intima-Media Thickness (CIMT), Mean Platelet Volume (MPV) and Epicardial Fat Thickness (EFT).
📊
Key Findings & Data:Patients and Methods: OSAS patients who have 5 or more AHI score were enrolled in the study.
💡
Conclusion & Impact:In our study, no differences were shown between the progression of the disease and endothelial dysfunction and pre-atherosclerosis markers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To investigate endothelial dysfunction and pre-atherosclerosis in patients with Obstructive Sleep Apnea Syndrome (OSAS) by using several parameters including Brachial Artery Flow-Mediated Vasodilation (BAFMV), Carotid Intima-Media Thickness (CIMT), Mean Platelet Volume (MPV) and Epicardial Fat Thickness (EFT). Patients with OSAS were classified according to the Apnea-Hypopnea Index (AHI). Patients and Methods: OSAS patients who have 5 or more AHI score were enrolled in the study. Patients with hypertension, hyperlipidemia, diabetes mellitus and cardiovascular diseases were excluded. Patients were classified as mild (5-10), moderate (16-30) and severe (>30) according to AHI. These groups were compared to each other in terms of endothelial dysfunction and pre-atherosclerosis markers including BAFMV, CIMT, MPV and EFT. Groups were compared statistically by using either Student’s T-Test or Mann Whitney–U test. Results: Our study population consists of 23 patients with OSAS (16 male, 7 female) with the mean age of 46.30±9.51 years ranging from 31-65 years. There were no significant differences in all parameters between the mild (5-10), moderate (16-30) and severe (>30) groups according to AHI. Conclusion: It is well known that patients with OSAS have an increased cardiovascular risk. In our study, no differences were shown between the progression of the disease and endothelial dysfunction and pre-atherosclerosis markers.

Özet

Amaç: Obstrüktif Uyku Apne Sendromu (OUAS) saptanan hastalarda vasküler endoteliyel işlev bozukluğu ve preaterosklerozis;brakial arter akım aracılı vazodilatasyon (BAAV), karotis arter intima-media kalınlığı (KIMK), mean platelet volume (MPV) veepikardiyal yağ dokusu (EYD) ölçümü yapılarak değerlendirildi. OUAS hastaları Apne-hipopne indekslerine (AHI) göre gruplaraayrılarak kıyaslandı.Hastalar ve Yöntem:Hastanemize uyku bozukluğu nedeni ile başvuran ve polisomniografi ile yapılan değerlendirmede AHİ değeri5 ve üstünde bulunan, hiperlipidemi, hipertansiyon, diyabetes mellitus ve bilinen kalp-damar hastalığı olmayan, yaşları 30-70arası, kadın ve erkeklerden oluşan hastalar çalışmaya dahil edildi. Bu hastalar AHI derecelerine göre hafif-orta ve şiddetli şeklindegruplandırıldı. Preateroskleroz KIMK, EYD kalınlığı ve MPV ile vasküler fonksiyon ve endotel hücre vazodilatasyonu ise BAEF bakılarak değerlendirildi. İstatistik olarak iki grup arasındaki farklılıklar değerlendirilmek istendiğinde parametrik test ön şartlarınısağladığı durumda “Student’s t Test”; sağlamadığında ise “Mann Whitney–U testi” kullanıldı.Bulgular: 23 hastanın 16 tanesi erkek, 7 tanesi kadındır. Yaş ortalaması 46,30+9,51 (31-65 yaş arası). Hastalar AHI indekslerinegöre (hafif:5-15, orta:16-30, şiddetli >30) olarak gruplandırıldığında karşılaştırma için kullanılan parametrelerde anlamlı farklılık saptanmadı.Sonuç: OUAS hastalarında kardiyovasküler riskin arttığı bilinmektedir. Çalışmamızda bu hastalarda hastalığın şiddeti ile preateroskleroz ve endotel fonksiyonun bozulması arasında bağlantı bulunmamıştır.

🔖

Cite This Article

AĞILDERE, M., SATILMIŞ, B. Ş., EŞKİ, E., AYDIN, E., ALTIN, C., TEKİNDAL, M. A. (2022). INVESTIGATION OF ENDOTHELIAL DYSFUNCTION AND THE RISK OF ATHEROSCLEROSIS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 10 - Sayı: 4, 627–633. https://ajindex.com/articles/427443

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Karadağ M, Yavuz Z. Uyku Apne Sendromu. Erişim: http:// uykubozuklugu.uludag.edu.tr/literatur1.htm Köktürk O. Uykuda solunum bozuklukları. Tarihçe, tanımlar, hastalık spektrumu ve boyutu. Tüberküloz Toraks Derg 1998;46:187–92.
  2. Carlson JT, Hedner JA, Ejnell H, Peterson LE. High prevelance of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994;150:72–7. [CrossRef] Linberg E, Janson C, Gislason T, Svärdsudd K, Hetta J, Boman G. Snoring and hypertension: a 10 year follow up. Eur Respir J 1998;11:884–9. [CrossRef] Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of slep-disordered breating, sleep apnea, and hypertension in large community based study. JAMA 2000;283:1829– 36. [CrossRef] Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479– 82. [CrossRef] Silverberg DS, Oksenberg A. Essential hypertension and abnormal upper airway resistance during sleep. Sleep 1997;20:794–806. [CrossRef] Andreas S, Schul R, Werger G, Kreuzer H. Prevalence of obstructive sleep apnea in patients with coronary artery disease. Cor Artery Dis 1996;7:541–5.
  3. Schafer H, Koahler U, Ploch T, Peter JH. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997;111:387–93. [CrossRef] Quan SF, Howard BV, Iber C, Kiley JP, Nieto FJ, O’Connor GT, et al. The Sleep Heart Healty Study: Design, rationale, and methods. Sleep 1997;20:1077–85. [CrossRef] Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased Incidens of Cardiovascular Disease in Middle-aged Men with Obstructive Sleep apnea: A 7-year Follow-up. Am J Respir Crit Care Med 2002;166:159– 65. [CrossRef] Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleepdisordered breathing in men with coronary artery disease. Chest 1996;109:659–63. [CrossRef] Chung S, Yoon IY, Shin YK,, Lee CH, Kim JW, Lee T, et al. Endothelial Dysfunction and C-Reactive Protein in Relation with the Severity of Obstructive Sleep Apnea Syndrome. Sleep 2007;30:997–1001. [CrossRef] Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159–69. [CrossRef] American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010;33:S62–9. [CrossRef] Poredos P. Intima-media thickness: indicator of cardiovascular